Samsung’s Latest Best-in-Class Technologies Take Center Stage at RSNA 2022
Posted on 25 Nov 2022
Samsung Electronics (Suwon-si, South Korea) is unveiling its latest artificial intelligence (AI) technologies and presenting its premium diagnostic solutions in ultrasound, digital radiography (DR) and mobile computed tomography (CT) at the Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting from November 27 to December 1.
At RSNA 2022, Samsung is highlighting its achievements this year that empower clinicians to diagnose their patients more confidently. At the event, Samsung is showcasing its leading product updates, including the V7 ultrasound system, a new endocavity transducer and new real-time on-device AI solutions. The new on-device AI solution for ultrasound, known as HeartAssist, which can enhance the diagnosis and examination process, is on display. This deep learning-based function automatically finds the cross-section of the heart and measures different points needed for an accurate diagnosis. The automated nature allows for a streamlined workflow due to fewer keystrokes. The feature can be found on Samsung’s V8 and V7 ultrasound systems. The miniER7, a new endocavity transducer, is being shown alongside the V7 ultrasound system. With a radius size of 7mm — 3mm smaller than the existing probe — the new probe has been designed to ease the burden felt by healthcare professionals as well as the discomfort that patients often experience during prostate ultrasound scanning. The miniER7 has been created with state-of-the-art micro-processing technology to capture clear images at a reduced file size.
Samsung is also showcasing its premium digital radiography solutions, including the new “Vision Assist” solution and AccE Glass Free Detector. The AccE GC85A Vision2 premium ceiling digital radiography system with “Vision Assist” provides more enhanced patient care and workflow efficiency maintaining an advanced low-dose imaging experience. Samsung also recently released a new flagship detector, the AccE Glass-Free Detector, which offers a more comfortable imaging experience without compromising image quality.
Samsung is also showcasing the OmniTom Elite with Photon Counting Detector (PCD) technology and BodyTom 64. The state-of-the-art OmniTom Elite has the ability to provide versatile, real-time mobile imaging to administer point-of-care CT to critical patients without the need to transport them to a separate imaging department. With the addition of PCD technology, the system provides the ability to capture CT data in multiple energy bands. The BodyTom 64 is an upgraded version of the BodyTom Elite CT scanner, providing enhanced functionality with high-resolution imaging capabilities. The head-to-toe trauma imaging solution boasts revisions based on customer feedback, with indications for both pediatric and adult imaging and can be used for low dose lung cancer screening. The BodyTom 64 is a multi-departmental imaging solution that can be utilized in neurosurgery, interventional radiology, brachytherapy, trauma, medical examination and more.
“Samsung has a long-standing history of leading the charge in technology advancements – 2022 has been a testament to this as we have worked to redefine our cutting-edge solutions across modalities. We’re now deploying real-time on-device AI technology to help healthcare professionals examine and diagnose patients with ease and accuracy from the start,” said David Legg, Vice President, Head of Business, Boston Imaging, a subsidiary of Samsung.
“Innovation is at the core of Samsung’s business. We take great pride in delivering our customers’ leading-edge technology on all Samsung devices,” said Kyu Tae Yoo, Senior Vice President, Global Head of Sales and Marketing, Samsung Medison. “As we look to expand diagnostic possibilities and improve the clinical experience that our customers need, we will keep healthcare professionals and the patients they treat top of mind.”
Related Links:
Samsung Electronics
